Expression of the ubiquitin-proteasome pathway and muscle loss in experimental cancer cachexia
2005

Muscle Loss in Cancer Cachexia and the Ubiquitin-Proteasome Pathway

publication Evidence: moderate

Author Information

Author(s): Khal J, Wyke S M, Russell S T, Hine A V, Tisdale M J

Primary Institution: Pharmaceutical Sciences Research Institute, Aston University

Hypothesis

The study investigates the role of the ubiquitin-proteasome pathway in muscle protein degradation during cancer cachexia.

Conclusion

The ubiquitin-proteasome pathway significantly contributes to protein loss in muscle up to 20% weight loss, but other factors may play a larger role at higher weight losses.

Supporting Evidence

  • Muscle protein degradation is linked to the ubiquitin-proteasome pathway in cancer cachexia.
  • Expression of proteasome components increased with weight loss up to 20%.
  • At higher weight losses, other factors may contribute more significantly to muscle protein loss.

Takeaway

When cancer patients lose weight, their muscles break down proteins faster, especially up to a certain point, but after losing too much weight, other reasons might cause muscle loss.

Methodology

The study used quantitative RT-PCR and immunoblotting to measure mRNA and protein levels of proteasome components in mouse muscle.

Limitations

The study only measured expression after weight loss had developed and did not compare different muscle types extensively.

Participant Demographics

Mice bearing the MAC16 adenocarcinoma model were used in the study.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6602780

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication